Theory-driven development of a medication adherence intervention delivered by eHealth and transplant team in allogeneic stem cell transplantation: the SMILe implementation science project.

Background: Medication adherence to immunosuppressants in allogeneic stem cell transplantation (alloSCT) is essential to achieve favorable clinical outcomes (e.g. control of Graft-versus-Host Disease). Over 600 apps supporting medication adherence exist, yet they lack successful implementation and s...

Descripción completa

Detalles Bibliográficos
Publicado en:BMC Health Services Research Vol. 20; no. 1; pp. 1 - 23
Autores principales: Ribaut, Janette, Leppla, Lynn, Teynor, Alexandra, Valenta, Sabine, Dobbels, Fabienne, Zullig, Leah L., De Geest, Sabina, the SMILe study team, Beckmann, Sonja, Mielke, Juliane, Schmid, Anja, Duerinckx, Nathalie, Heidegger, Phillip, Fürmann, Margarita, Neupert, Daniela, Rockstein, Dennis, Werlitz, Viktor, Fürmann, Michael, Schulz, Tobias, Lemcke, Marina
Formato: Journal Article
Publicado: BioMed Central 9/2/2020
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=145653266&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 145653266
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        14726963
        1CHS
      jtl: BMC Health Services Research
      issn: 14726963
      maglogo: N
    pubinfo:
      dt: 9/2/2020
      vid: 20
      iid: 1
      pid: 24147
      pub: BioMed Central
    artinfo:
      ui:
        145653266
        145653266
        NLM32878623
        10.1186/s12913-020-05636-1
        NLM32878623
        145653266
      ppf: 1
      ppct: 22
      formats:
      tig:
        atl: Theory-driven development of a medication adherence intervention delivered by eHealth and transplant team in allogeneic stem cell transplantation: the SMILe implementation science project.
      aug:
        au:
          Ribaut, Janette
          Leppla, Lynn
          Teynor, Alexandra
          Valenta, Sabine
          Dobbels, Fabienne
          Zullig, Leah L.
          De Geest, Sabina
          the SMILe study team
          Beckmann, Sonja
          Mielke, Juliane
          Schmid, Anja
          Duerinckx, Nathalie
          Heidegger, Phillip
          Fürmann, Margarita
          Neupert, Daniela
          Rockstein, Dennis
          Werlitz, Viktor
          Fürmann, Michael
          Schulz, Tobias
          Lemcke, Marina
        affil: Department Public Health, Faculty of Medicine, Institute of Nursing Science, University of Basel, Bernoullistrasse 28, 4056, Basel, Switzerland
      sug:
        subj:
          Hematopoietic Stem Cell Transplantation
          Medication Compliance
          Telemedicine Methods
          Immunosuppression
          Immunosuppressive Agents Therapeutic Use
          Scales
      ab: Background: Medication adherence to immunosuppressants in allogeneic stem cell transplantation (alloSCT) is essential to achieve favorable clinical outcomes (e.g. control of Graft-versus-Host Disease). Over 600 apps supporting medication adherence exist, yet they lack successful implementation and sustainable use likely because of lack of end-user involvement and theoretical underpinnings in their development and insufficient attention to implementation methods to support their use in real-life settings. Medication adherence has three phases: initiation, implementation and persistence. We report the theory-driven development of an intervention module to support medication adherence (implementation and persistence phase) in alloSCT outpatients as a first step for future digitization and implementation in clinical setting within the SMILe project (Development, implementation and testing of an integrated care model in allogeneic SteM cell transplantatIon faciLitated by eHealth).Methods: We applied Michie's Behavior Change Wheel (BCW) and the Capability-Opportunity-Motivation and Behavior (COM-B) model using three suggested stages followed by one stage added by our team regarding preparation for digitization of the intervention: (I) Defining the problem in behavioral terms; (II) Identifying intervention options; (III) Identifying content and implementation options; (IV) SMILe Care Model Prototype Development. Scientific evidence, data from a contextual analysis and patients'/caregivers' and clinical experts' inputs were compiled to work through these steps.Results: (I) Correct immunosuppressant taking and timing were defined as target behaviors. The intervention's focus was determined within the COM-B dimensions Capability (lack of knowledge, lack of routine), Opportunity (lack of cues, interruptions in daily routine) and Motivation (lack of problem solving, trivialization). (II) Five intervention functions were chosen, i.e. education, training, modelling, persuasion and enablement. (III) Twenty-four behavior change techniques were selected, e.g., goal setting, action planning and problem solving. (IV) Finally, seventeen user stories were developed to guide the SMILeApp's software development process.Conclusion: Our example on the theory-driven development of an intervention module in alloSCT delivered by eHealth and transplant team using a rigorous 3 + 1-stage approach based on BCW, COM-B and agile software development techniques, can be used as methodological guidance for other eHealth intervention developers. Our approach has the potential to enhance successful implementation and sustained use of eHealth solutions in real-life settings.
      pubtype: Academic Journal
      doctype: Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N